Skip to main content

Month: March 2022

Whole Earth Brands Reports Fourth Quarter and Full Year 2021 Results and Provides 2022 Guidance

CHICAGO, March 14, 2022 (GLOBE NEWSWIRE) — Whole Earth Brands, Inc. (the “Company” or “we” or “our”) (Nasdaq: FREE), a global food company enabling healthier lifestyles through premium plant-based sweeteners, flavor enhancers and other foods, today announced its financial results for its fourth quarter and full year ended December 31, 2021. The Company also provided initial 2022 guidance. Full Year HighlightsReported consolidated revenue growth of 79%, including strategic acquisitions Branded CPG proforma organic constant currency revenue growth of approximately 12% on a two-year stacked basis versus 2019 and approximately 1% compared to 2020 Flavors & Ingredients revenue growth of approximately 7% compared to 2020 Operating income of $22.8 million and adjusted EBITDA of $82.2 million, an increase of approximately 51%Fourth...

Continue reading

Intelsat Expands In-Flight Connectivity Capabilities with Strategic Multimillion-Dollar Order for Gilat’s SkyEdge IV Taurus Modems

Gilat’s SkyEdge IV Taurus modems enhance user experience of Intelsat’s global network with high-quality IFC for commercial aviation, regional aircraft, and business jets while leveraging interoperability with SkyEdge II-c PETAH TIKVA, Israel, March 14, 2022 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, announced today that Intelsat is expanding its in-flight connectivity (IFC) capabilities with a strategic multimillion-dollar order for Gilat’s SkyEdge IV Taurus modems. SkyEdge IV Taurus is an ultra-high-performance modem for IFC designed to provide Wi-Fi internet and IPTV for passengers on commercial airlines, regional aircraft and business jets. Taurus is backward compatible, thus preserving past investments...

Continue reading

Myriad Genetics Advances Precision Oncology with New Precise™ Solutions, Combines Genetic Insights from Multiple Tests to Guide Treatment Decisions and Improve Patient Care

Company launches Precise™ Tumor test, part of a comprehensive suite combining germline, tumor and companion diagnostics in one easy-to-access solution SALT LAKE CITY, March 14, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the launch of Precise™ Oncology Solutions, a comprehensive offering designed to help oncologists determine effective and personalized treatment plans for individual patients. The new suite provides physicians with streamlined testing that combines germline testing, tumor profiling and companion diagnostic options including evaluation for Homologous Recombination Deficiency (HRD), an important cancer repair pathway. Precise Oncology Solutions includes Myriad’s new Precise™ Tumor Molecular Profile Test, developed in collaboration...

Continue reading

Verve Therapeutics Announces Pipeline Progress and Reports Fourth Quarter and Full Year 2021 Financial Results

Significant Progress Anticipated in 2022 with Initiation of Clinical Trial for VERVE-101 and IND-enabling Studies for ANGPTL3 Program Presentations at Upcoming Scientific Conferences to Highlight Novel Base Editing Approach and Proprietary Lipid Nanoparticle Delivery System Cash, Cash Equivalents and Marketable Securities of $360.4 Million with Cash Runway into 2024 CAMBRIDGE, Mass., March 14, 2022 (GLOBE NEWSWIRE) — Verve Therapeutics, Inc., (Nasdaq: VERV), a biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today reported pipeline highlights and fourth quarter and full year 2021 financial results. Verve’s programs are designed to mimic natural disease resistance mutations and turn off specific genes, such as PCSK9 and ANGPTL3, in order to lower blood...

Continue reading

Bright Minds Biosciences Announces Successful Completion of 28-Day Toxicology Studies and Advancement to First-in-Human Clinical Trial

VANCOUVER, British Columbia, March 14, 2022 (GLOBE NEWSWIRE) — Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE: DRUG), a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders, epilepsy, and pain, today announced the successful completion of 28-day repeat-dose toxicity studies for its lead product, BMB-101. Importantly, there were no major toxicological findings after twice daily oral administration of BMB-101 throughout the study period. The studies were conducted by the Company’s contract research partner, ITR Laboratories Canada in Baie d’Urfé, Québec, Canada. Dr. Revati Shreeniwas, Bright Minds’ Chief Medical Officer, stated, “Dravet Syndrome, a severe form of epilepsy characterized by frequent, prolonged seizures, is a terribly...

Continue reading

BW Offshore: Recycling the FPSO Umuroa in compliance with Hong Kong Convention

Recycling the FPSO Umuroa in compliance with Hong Kong Convention BW Offshore has signed an agreement to recycle the FPSO Umuroa in compliance with the Hong Kong International Convention at Baijnath Melaram (‘the Yard’) in India. The sale will generate USD 13.5 million in net liquidity. The Yard is certified to ISO standards and has been issued with a Statement of Compliance by Class NK in accordance with the IMO Resolution MEPC.210(63) and the Hong Kong International Convention for the safe and environmentally sound recycling of ships. BW Offshore will nominate a third-party to be on site at the recycling yard to ensure Health, Safety and Environmental regulations are followed. A Ship Recycling Plan has been prepared and provided by the Yard in cooperation with the Gujarat Maritime Board in compliance with the above regulations. To further...

Continue reading

ESE Takes the Win in the 2022 MUSE Creative Awards For the SkillzVault By Bitcoin Vault Campaign

VANCOUVER, British Columbia, March 14, 2022 (GLOBE NEWSWIRE) — ESE Entertainment Inc. (“ESE” or the “Company”) (TSXV: ESE) (OTCQB: ENTEF) is pleased to announce that it has been selected as a 2022 Gold Winner in the 2022 Muse Creative Awards for its work on the SkillzVault by Bitcoin Vault project, which was organized in 2021 in Asia and South America and was previously disclosed in the Company’s news release on May 6, 2021. A list of Season 1 winners for the 2022 MUSE Creative and Design Awards has been officially released by the International Awards Associate (“IAA”). Having received over 6,000 entries from all over the globe, the MUSE Creative Awards and MUSE Design Awards are two leading award programs created to honour creative and design professionals for their excellence. ESE was selected as a 2022 Gold Winner under the...

Continue reading

Solstice Field Work Supports 16km Extension of the Red Lake Gold Camp

Drill Targets Developing for 2022 Exploration ProgramFigure 1. -80m conductivity slice of EM 3d voxel with fault interpretation on shadowed regional OGS magnetic base. Area of new staking shown in yellow covering fault extensions. Nungessor Shear Zone from OGS mapping. Areas of potential seismic structures shown as E1 and E2 on inset map.Figure 2. Elevated Gold in soils (humus) plotted on the -80m conductivity slice with fault interpretation on shadowed regional OGS magnetic base. Area of new staking shown in yellow covering fault extensions.Figure 3. Central Grid Ah (humus) gold-arsenic-molybdenum soils plotted on -80m conductivity slice fault interpretation on shadowed regional OGS magnetic base (scale as in Figs 1 and 2). See text for further details.Figure 4. North Grid Ah (humus) gold-arsenic-molybdenum data on -80m...

Continue reading

Willis Lease Finance Corporation Reports Annual Pre-tax Profit of $9.1 million

COCONUT CREEK, Fla., March 14, 2022 (GLOBE NEWSWIRE) — Willis Lease Finance Corporation (NASDAQ: WLFC) today reported annual total revenues of $274.2 million and pre-tax profit of $9.1 million. For the year ended December 31, 2021, aggregate lease rent and maintenance reserve revenues were $208.8 million and spare parts and equipment sales were $17.4 million. The Company reported increased total revenues in the fourth quarter when compared to the prior year period, primarily due to both an increase in lease rent revenue and gain on sale of leased equipment and financial assets, partially offset by a reduction in long-term maintenance revenue. “We continued to see a slow recovery during the second half of 2021 as travel began to open on a global basis only to be dampened again near year-end by COVID-19 variants,” said Charles F....

Continue reading

Li Auto Announces Inclusion of Its Shares in the Shenzhen-Hong Kong Stock Connect Program

BEIJING, March 14, 2022 (GLOBE NEWSWIRE) — Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), an innovator in China’s new energy vehicle market, today announced that the Company’s Class A ordinary shares, which are listed and traded on the Stock Exchange of Hong Kong Limited (“HKEX”), have been included in the Shenzhen-Hong Kong Stock Connect program, effective on March 14, 2022, based on the announcement of the Shenzhen Stock Exchange. The inclusion in the Shenzhen-Hong Kong Stock Connect program allows the Company to access a broader investor base and share its growth trajectory and further success with users, partners and investors in mainland China via the financial market. The Company was selected as a constituent stock of the Hang Seng Composite Index and its sub-indexes, including the Hang Seng Composite...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.